NCT03318432 Stroke Recovery Initiative - Registry for Stroke Research Studies
| NCT ID | NCT03318432 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 60,000 participants |
| Start Date | 2013-02-09 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60,000 participants in total. It began in 2013-02-09 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Stroke Recovery Initiative is a nation-wide participant recruitment registry that connects people who have had a stroke with researchers who are working to develop new approaches to improve recovery after stroke.
Eligibility Criteria
* 18 years of age or older * Have suffered a stroke * Have ongoing symptoms as a result of the stroke
Contact & Investigator
Anthony S. Kim, MD, MAS
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT03318432 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03318432 currently recruiting?
Yes, NCT03318432 is actively recruiting participants. Contact the research team at strokerecoveryinitiative@ucsf.edu for enrollment information.
Where is the NCT03318432 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT03318432 clinical trial?
NCT03318432 is sponsored by University of California, San Francisco. The principal investigator is Anthony S. Kim, MD, MAS at University of California, San Francisco. The trial plans to enroll 60,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.